Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis
| Project/Area Number |
17K16527
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
Maeda Shimpei 東北大学, 医学系研究科, 大学院非常勤講師 (90455824)
|
|---|
| Project Period (FY) |
2017-04-01 – 2019-03-31
|
| Project Status |
Completed (Fiscal Year 2018)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | 膵頭部癌 / タンパク質バイオマーカー / 遠位胆管癌 / 免疫組織化学 / 膵癌 / 胆管癌 / バイオマーカー / 免疫染色 / 癌 |
|---|
| Outline of Final Research Achievements |
Ten PHC and 8 DCC specimens were analyzed by LC-MS/MS. Selected proteins were evaluated, using immunohistochemical analysis, to determine whether they would be appropriate biomarkers. Finally, we generated biomarker panels to improve diagnostic accuracy. 1820 proteins were detected using LC-MS/MS. Fifteen differentially expressed proteins were selected as candidates based on semi-quantitative comparison. We first performed immunohistochemical staining on samples from the small cohort group using 15 candidates. KRT17, ANXA10, TMEM109, PTMS, and ATP1B1 showed favorable performances and were tested in the next large cohort group. KRT17 performed best for the diagnosis of PHC as a single marker; additionally, PTMS exhibited good performance for the diagnosis of DCCs. Moreover, we indicated the KRT17+/ANXA10+/PTMS- staining pattern as a biomarker panel for the correct diagnosis of PHC.
|
| Academic Significance and Societal Importance of the Research Achievements |
タンパク質発現プロファイルを解析し、免疫組織化学的検証を経て、膵頭部癌と遠位胆管癌の診断を可能とする5種類のタンパク質を同定した。膵頭部癌の診断に有用なバイオマーカーは、単独ではKRT17であり、バイオマーカーパネルとしてはKRT17陽性/ANXA10陽性/TMEM109陽性を示す表現型であった。一方遠位胆管癌の診断に最も有用なバイオマーカーはPTMSであり、バイオマーカーパネルはKRT17陰性/ANXA10陰性/ PTMS陽性を示す表現型であった。これらのバイオマーカーは膵頭部癌と遠位胆管癌の新規鑑別診断マーカーとして有望であり、現状では鑑別困難な症例に臨床応用できる可能性がある。
|
Report
(3 results)
Research Products
(4 results)
-
[Journal Article] Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis2019
Author(s)
Tsutomu Takenami, Shimpei Maeda, Hideaki Karasawa, Takashi Suzuki, Toru Furukawa, Takanori Morikawa, Tatsuyuki Takadate, Hiroki Hayashi, Kei Nakagawa, Fuyuhiko Motoi, Takeshi Naitoh and Michiaki Unno
-
Journal Title
Related Report
Peer Reviewed / Open Access
-
[Presentation] 膵頭部癌・遠位胆管癌の鑑別診断を可能とするタンパク質バイオマーカーの同定2018
Author(s)
竹浪 努, 前田晋平, 唐澤秀明, 鈴木 貴, 高舘達之, 水間正道, 大塚英郎, 森川孝則, 林 洋毅, 中川 圭, 元井冬彦, 内藤 剛, 亀井 尚, 石田孝宣, 海野倫明
Organizer
第118回日本外科学会定期学術集会
Related Report
-
-
